MethodAdded (g mL-1 )BCGBTB5.0 10 15 5.0 TrkA site 10Recovery 99.ten 100.20 99.40 99.30 99.50 one hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE
MethodAdded (g mL-1 )BCGBTB5.0 10 15 five.0 10Recovery 99.10 one hundred.20 99.40 99.30 99.50 one hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE -0.90 0.20 -0.60 -0.70 -0.50 0.50 Self-confidence limitb four.955 0.021 ten.02 0.078 14.91 0.173 4.965 0.026 9.95 0.09 20.ten 0.231 Recovery 99.60 99.80 99.20 100.60 99.40 99.Precision RSD a 0.51 0.75 1.02 0.40 0.68 0.Interday Accuracy RE -0.40 0.20 -0.80 0.60 -0.60 -0.Confidence limitb 4.98 0.025 9.98 0.075 14.88 0.152 5.03 0.020 9.94 0.068 19.92 0.abMean of six determinations; RSD : percentage relative normal deviation; RE : percentage relative error. Self-assurance limit at 95 confidence level and five degrees of freedom ( = 2.571).RSK3 custom synthesis Journal of Analytical Approaches in ChemistryJournal of Analytical Approaches in ChemistryTable 5: Determination of GMF in its pharmaceutical dosage forms applying the common addition technique.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCG2.BCP2.BPB2.BTB5.MO4.0 8.0 12 2.0 six.0 10 4.0 eight.0 12 4.0 eight.0 12 five.0 10Factive tablets Flobiotic tablet GemiQue tablets Total located (g mL-1 ) Recovery a SD Total discovered (g mL-1 ) Recovery SD Total identified (g mL-1 ) Recovery SD five.96 99.30 0.78 five.98 99.60 0.67 6.02 100.30 0.51 9.91 99.ten 1.02 10.02 one hundred.20 0.82 9.92 99.20 0.70 13.97 99.80 1.24 13.96 99.70 1.09 13.99 99.90 0.94 three.996 99.90 0.66 3.96 99.ten 0.42 three.97 99.30 0.38 8.02 one hundred.20 0.90 7.98 99.80 0.69 7.99 99.90 0.84 11.92 99.30 0.95 12.05 one hundred.40 1.03 11.95 99.60 1.17 5.97 99.50 0.57 5.99 99.80 0.36 six.01 100.15 0.76 9.97 99.70 0.76 9.96 99.60 0.49 9.97 99.70 0.96 13.87 99.ten 1.14 13.97 99.90 0.78 13.89 99.20 1.21 six.03 100.50 0.48 6.01 one hundred.10 0.53 6.01 100.10 0.54 9.90 99.00 0.72 9.96 99.60 0.85 9.96 99.60 1.03 13.93 99.50 0.97 13.96 99.70 1.31 14.04 one hundred.30 1.15 9.97 99.70 0.32 9.91 99.10 0.70 9.99 99.90 0.65 14.94 99.60 0.56 15.06 one hundred.40 1.05 14.97 99.80 0.85 24.95 99.80 0.90 24.88 99.50 1.25 24.90 99.60 1.aAverage of six determinations.Table 6: Determination of MXF in its pharmaceutical dosage types applying the regular addition strategy.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCP2.BPB2.BTB5.MO2.0 6.0 10 4.0 8.0 12 two.0 four.0 8.0 5.0 10Avelox tablets Moxiflox tablets Moxifloxacin tablets Total discovered (g mL-1 ) Recovery a SD Total identified (g mL-1 ) Recovery SD Total located (g mL-1 ) Recovery SD three.98 99.40 0.56 3.96 99.10 0.62 3.98 99.60 0.48 7.98 99.70 0.83 8.06 one hundred.70 0.89 7.98 99.80 1.ten 11.89 99.ten 1.20 12.02 100.20 1.26 11.92 99.30 1.17 5.98 99.60 0.61 5.97 99.50 0.35 5.96 99.30 0.36 9.99 99.90 0.84 9.96 99.60 0.60 9.99 99.90 0.63 14.07 100.50 1.14 13.99 99.90 0.85 14.08 one hundred.60 1.36 three.98 99.50 0.48 3.97 99.20 0.33 4.01 one hundred.20 0.61 five.95 99.20 0.92 5.99 99.80 0.65 5.96 99.30 0.84 10.04 one hundred.40 1.17 10.01 one hundred.ten 0.93 9.95 99.50 1.07 9.91 99.ten 0.42 9.94 99.40 0.37 9.95 99.50 0.45 15.08 100.50 0.76 15.03 one hundred.20 0.75 14.97 99.80 0.85 19.90 99.50 1.16 19.92 99.60 1.28 19.83 99.15 0.Journal of Analytical Strategies in ChemistryaAverage of six determinations.Journal of Analytical Techniques in ChemistryTable 7: Determination of ENF in its pharmaceutical dosage forms applying the regular addition method. ReagentTaken (g mL-1 ) Pure drug added (g mL-1 ) 5.0 BCG 5.0 BBTBa5.0 ten 15 five.0 10Enrocin 10 injectable Avitryl 20 injectable Total identified (g mL-1 ) Recovery a SD Total located (g mL-1 ) Recovery SD 9.92 99.20 0.48 9.94 99.40 0.46 14.94 99.60 0.66 15.20 100.ten 0.72 19.98 10.05 14.91 19.84 99.90 0.82 one hundred.50 0.56 99.40 0.83 99.20 1.20 19.90 9.97 15.05 19.82 99.50.